Patients experience higher disease activity, lower quality of life, and worse physical functioning.
Associated comorbidities can bias clinical disease activity measures.
A study spanning 18 years confirms that arthritis is up, people are being diagnosed at a younger age and with a higher BMI.
There is no definitive evidence to suggest that obesity is associated with an increased risk of rheumatoid arthritis, but there is evidence that links obesity to more active disease and lack of treatment response. In this slideshow, we review the evidence.
In this slideshow, we highlight some of the upcoming studies due to be presented at the American College of Rheumatology 2016 annual meeting which begins Nov. 11 in Washington, D.C.
Obesity was a common theme at RNS16 this year in which speakers touched on obesity as a cause of disease onset and even as one that can prevent therapeutic treatments from working.
Obesity, a strong risk factor for gout, is associated with an earlier age at gout onset. In addition, the risk of gout is increased with obesity in women as well as in men.
The prevalence of gout in the United States has risen over the past 20 years and now affects 8.3 million Americans, or 4% of the population, according to a study reported in a recent issue of Arthritis & Rheumatism, an American College of Rheumatology (ACR) publication.
Walking at a slow speed up a moderate incline is an alternative exercise strategy for obese adults that may reduce the risk of musculoskeletal injury and pathological disease associated with brisk, level walking and provide proper cardiovascular stimulus for weight management.
A combination of weight loss and exercise provides greater benefit than either intervention alone.